TMCITreace Medical Concepts, Inc.

$104M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$41M+23.3% YoY

Gross Profit

$33M80.4% margin

Operating Income

-$18M-43.7% margin

Net Income

-$18M-43.0% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-2.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$240M

Total Liabilities

$103M

Stockholders' Equity

$138M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$33M	+23.3%
Gross Profit	$33M	$27M	+21.5%
Operating Income	-$18M	-$11M	-57.4%
Net Income	-$18M	-$12M	-44.4%

TMCI Q3 2023 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena